NCT02807246View on ClinicalTrials.gov

Effects of Probiotics on Neonatal Hyperbilirubinemia

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions

Neonatal Hyperbilirubinemia

Interventions

BIOLOGICAL

Maflor®, Mamsel Pharmaceuticals, Turkey

"Dietary Supplement: Probiotics probiotics at a dose of 1x109 CFU/day. (Maflor®, Lactobacillus rhamnosus GG 109 CFU, Mamsel Pharmaceuticals, Turkey)~Other Name: Maflor®"

OTHER

drops of saline

Dietary Supplement: Breast milk +drops of saline

All Listed Sponsors

lead

Karadeniz Technical University

OTHER

NCT02807246 - Effects of Probiotics on Neonatal Hyperbilirubinemia | Biotech Hunter | Biotech Hunter